Capital Research Global Investors Purchases 7,784 Shares of Nutrien Ltd. $NTR

Capital Research Global Investors increased its position in Nutrien Ltd. (NYSE:NTR) by 0.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,151,049 shares of the company’s stock after purchasing an additional 7,784 shares during the quarter. Capital Research Global Investors owned approximately 0.24% of Nutrien worth $71,043,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Swiss Life Asset Management Ltd grew its stake in Nutrien by 23.6% in the third quarter. Swiss Life Asset Management Ltd now owns 79,770 shares of the company’s stock worth $4,691,000 after purchasing an additional 15,230 shares in the last quarter. Van ECK Associates Corp grew its stake in Nutrien by 1.4% in the third quarter. Van ECK Associates Corp now owns 1,854,650 shares of the company’s stock worth $108,901,000 after purchasing an additional 25,588 shares in the last quarter. MH & Associates Securities Management Corp ADV bought a new position in Nutrien in the fourth quarter worth approximately $1,967,000. Hudson Bay Capital Management LP grew its stake in Nutrien by 190.3% in the third quarter. Hudson Bay Capital Management LP now owns 116,312 shares of the company’s stock worth $6,829,000 after purchasing an additional 76,244 shares in the last quarter. Finally, Metis Global Partners LLC grew its stake in Nutrien by 37.8% in the third quarter. Metis Global Partners LLC now owns 220,648 shares of the company’s stock worth $12,958,000 after purchasing an additional 60,491 shares in the last quarter. Institutional investors own 63.10% of the company’s stock.

Nutrien Stock Up 0.3%

Nutrien stock opened at $67.40 on Tuesday. The business has a fifty day moving average of $72.09 and a two-hundred day moving average of $68.97. The company has a quick ratio of 0.59, a current ratio of 1.24 and a debt-to-equity ratio of 0.35. The firm has a market cap of $32.35 billion, a P/E ratio of 13.73, a P/E/G ratio of 0.62 and a beta of 0.60. Nutrien Ltd. has a twelve month low of $53.03 and a twelve month high of $85.36.

Nutrien (NYSE:NTR) last posted its earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.03. The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.Nutrien’s revenue was up 18.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.11 earnings per share. On average, analysts forecast that Nutrien Ltd. will post 5.45 earnings per share for the current fiscal year.

Nutrien Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 3.3%. The ex-dividend date is Tuesday, June 30th. Nutrien’s dividend payout ratio is currently 44.81%.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Raymond James Financial raised Nutrien from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $74.00 to $90.00 in a research note on Tuesday, May 5th. Barclays upped their target price on Nutrien from $70.00 to $80.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 3rd. JPMorgan Chase & Co. upped their target price on Nutrien from $78.00 to $80.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. BNP Paribas Exane lowered Nutrien from an “outperform” rating to a “neutral” rating in a report on Monday, February 23rd. Finally, Oppenheimer upped their target price on Nutrien from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, May 12th. Eleven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Nutrien currently has a consensus rating of “Moderate Buy” and an average target price of $82.75.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.